The variant is associated with higher levels of IL-6 but lower levels of CRP, and is protective for a number of physical illnesses associated with inflammation such as coronary heart disease (CHD) (Collaboration et al., 2012, Swerdlow et al., 2012) and type-1 diabetes (Ferreira et al., 2013). The gene discussed is IL6; the disease is coronary artery disorder.